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Mitochondrial calcium accumulation and respiration in ischemic acute
renal failure in the rat. Changes in mitochondrial (Mito) calcium (Ca)
and Mito respiration have been demonstrated 24 hr after a renal
ischemic insult. The Ca accumulation has been suggested to contrib-
ute to impaired Mito function; alternatively, the Mito Ca accumula-
tion could be a late event resulting from cell death. The present aim
was, therefore, to determine the sequence of changes in Mito function
in ischemic acute renal failure (ARF) induced by 45 mm of bilateral
renal pedicle clamping in the rat. Animals were studied at the end of
clamping, 1, 4, and 24 hr after reflow. By 24 hr, the serum creatinine
level had risen progressively to almost ten times control values and
fractional excretion of sodium and water were increased. Mito respira-
tion (state 3, adenosine diphosphate-stimulated; acceptor control ratio,
state 3/state 4; and uncoupled, FCCP) was severely depressed immedi-
ately after 45 mm of clamping but improved significantly at I and 4 hr
after reflow although remaining below sham-operated controls. At 24
hr, when ischemic ARF was established, Mito respiration was again
severely depressed. Mito Ca was increased slightly but significantly
at the end of clamping and increased progressively at 1, 4, and 24 hr
after reflow. The Mito Ca accumulation was not only demonstrated
to occur very early after the ischemic insult, but was relatively selective
since it was not associated with Mito Mg accumulation. Moreover,
the increased Mito Ca during reperfusion (I, 4, and 24 hr) demon-
strated a significant correlation with the decreased state 3 respiration
and the rising serum creatinine level (P < 0.001). The results therefore
suggest that an early and progressive increase in Mito Ca may be
important in the pathogenesis of ischemic ARF. Alternatively, or in
addition, Mito Ca may be an indication of other cellular dysfunction
such as cellular membrane damage and associated increased
permeability.
Accumulation mitochondriale de calcium et respiration lors de l'insuffi-
sance rénale aiguë ischémique chez le rat. Des modifications du calcium
(Ca ) mitochondrial (Mito) et de Ia respiration Mito ont été demon-
trees 24 heures après une ischémie rénale. II a ete suggéré que
l'accumulation de Ca contribue a l'anomalie de fonction Mito; par
ailleurs, l'accumulation de Ca Mito pourrait Ctre un Cvènement tardif
découlant de Ia mort cellulaire. C'est pourquoi ce projet a été de
determiner Ia sequence des modifications de Ia fonction Mito dans
l'insuffisance rénale aigue (ARF) ischémique induite par une obstruc-
tion de 45 minutes bilatérale du pédicule renal chez le rat. Les animaux
ont été étudiés a Ia fin de l'obstruction, 1, 4, et 24 heures aprCs Ia
reperméabilisation. Au bout de 24 heures, le niveau de créatinine
sCnque s'est éleve progressivement a presque dix fois les valeurs
contrôles et l'excrCtion fractionnelle de sodium et d'eau était augmen-
tee. La respiration Mito (stade 3, stimulée par l'adénosine diphosphate;
rapport accepteur contrOle, stade 3/stade 4, et decouplCe FCCP) était
sévCrement déprimCe immédiatement après 45 minutes de clampage,
mais s'est améliorée significativement a I et 4 heures après Ia reperméa-
bilisation, bien que restant plus bas que les contrOles ayant subi un
simulacre d'opération. A 24 heures, quand l'ARF ischemique Ctait
installée, Ia respiration Mito était a nouveau sévérement deprimée. LeCa Mito était augmenté légérement mais significativement a Ia fin du
clampage, et s'élevait progressivement a i, , et 24 heures aprCs Ia
reperméabilisation. L'accumulation de Ca Mito ne survenait pas
seulement trés précocdment apres Ia lesion ischémique, mais était aussi
relativement selective, puisqu'elle n'était pas associée avec l'accumula-
tion de Mg Mito. En outre, l'augmentation du Ca Mito pendant Ia
reperfusion (1, 4, et 24 heures) démontrait une correlation significative
avec Ia diminution de Ia respiration de stade 3, et !'augmentation du
niveau de crCatinine serique (P < 0.001). Ces résultats suggCrent donc
qu'une augmentation precoce et progressive du Ca Mito pourrait être
importante dans Ia pathogenie de I'ARF ischemique. D'un autre côté,
en plus, le Ca Mito pourrait constituer une indication d'autres
dysfonctionnements cellulaires, comme une anomalie de Ia membrane
cellulaire, et une augmentation associée de Ia permeabilitC.
The functional and pathological changes associated with the
development of ischemic acute renal failure (ARF) have been
studied carefully [1—81. However, the intracellular changes
accompanying the abnormal physiology of in vivo ischemic
ARF have only recently been described in a preliminary manner
in norepinephrine-induced ischemic ARF in the dog [9]. At 24
hr after the ischemic insult, a decrease in renal mitochondrial
(Mito) oxidative phosphorylation and an increase in Mito
calcium (Ca) content were seen, both of which could be
prevented by verapamil [10] or mannitol [9] in association with
improved renal function. This is not a finding unique to the
kidney; an increase in cellular Ca concentration, both in the
cytosol and Mito, has been suggested to be involved as a
pathogenetic factor in ischemic cell death in the liver [11] and
heart [12, 13] as well as the kidney [9, 10, 14]. Furthermore, the
demonstration that chiorpromazine, an inhibitor of the Ca /
calmodulin complex, protects against ischemic liver [11] and
kidney [15] injury supports this possibility. Moreover, the
demonstration that Ca + membrane blockers provide protec-
tion against heart [16] and kidney ischemia [10, 17, 181 is also
compatible with this possibility.
Because of the protective effect of verapamil, a slow-channel
Ca blocking agent, on Mito and renal function, it was suggested
that increased cystolic Ca may be an important mediator of
renal vasoconstriction and epithelial cell necrosis which are
characteristic of ischemic ARF [9, 10] and have been docu-
mented by morphological [19] and micropuncture [19—21] stud-
ies. In this regard, using an in vitro model of renal ischemia,
Mergner et al [14] and Mergner, Smith, and Trump [22] have
also demonstrated Mito Ca accumulation and swelling as
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well as decreased Mito respiration. Moreover, Chien et a! [11]
have clearly shown the relationship between increased tissue
Ca and cell necrosis in experimental liver ischemia; after
myocardial ischemia, reperfusion is also accompanied by an
early and marked increase in cellular Ca [12, 13]. To our
knowledge, the temporal sequence and selectivity of Mito Ca
accumulation after an in vivo renal ischemic insult has however
not been studied previously.
The purpose of the present study was to determine the
sequence of early (0 to 4 hr) and late (24 hr) changes in Mito
respiration and Ca content in ischemic ARF induced by bilater-
al renal artery and vein clamping in the rat. In the absence of
such sequential studies, alterations in Mito respiration and Ca
content described at 24 hr postischemic insult [9, 10] could be
either the result or the cause of the renal failure. On the other
hand, early and selective increases in Mito Ca would be
compatible with a pathogenetic role in the initiation of ARF,
particularly if the increase was significantly correlated with
both Mito dysfunction and renal impairment.
Methods
Male Sprague-Dawley rats weighing 240 to 320 g were
subjected to either bilateral renal pedicle clamping of both
artery and vein, or sham operation under sodium pentobarbital
anesthesia (50 mg/kg i.p.) through small bilateral flank inci-
sions. Subsequently, the kidneys were removed at intervals for
the study of Mito respiration. Renal pedicle clamping was
performed for 45 mm using tightly occlusive clamps (1" Diefien-
bach, Miltex Instruments Co., Lake Success, New York). The
kidney was freed from penrenal fat and the adrenal gland prior
to pedicle clamping; after applying the clamp, the kidney was
replaced in its normal position and completely covered by the
tissues of the abdominal wall and skin. The ureter was not
clamped. In sham-operated rats, the kidneys were temporarily
exposed in a similar fashion to that used for pedicle clamping
but were not manipulated. After clamping or sham-operation,
the incisions were closed in layers. The animals were allowed to
recover prior to the removal of the kidneys for Mito studies.
Animals to be studied were sacrificed at the end of clamping
and after 1, 3 to 4, or 24 hr of reflow. Animals to be studied at 24
hr were placed in metabolic cages. They were allowed water but
no food overnight while urine samples were collected.
For the Mito studies, rats were anesthetized with sodium
pentobarbital (50 mg/kg), the abdomen was opened through a
vertical midline incision, and both kidneys were rapidly ex-
cised. The kidneys were divided in a saggital plane and immedi-
ately immersed in chilled media containing 210 mi mannitol, 70
m sucrose, 0.1 mM EGTA, and 0.5% BSA buffered at pH 7.4
with 2 mi K-Hepes. The use of EGTA, through its chelating
activity, may lead to some loss of Mito Ca during the
isolation procedure; conversely, failure to use EGTA could
result in in vitro Mito Ca accumulation. To obtain adequate
tissue samples for study, only the inner white medulla was
removed and the remaining tissue samples were scissor-minced
and homogenized (20% w/v) on ice for approximately 10 sec
using a homogenizer (Polytron, Brinkman Instruments, West-
bury, New York). Thus, any observed defects in Mito function
could be from damaged tissue of cortex, outer medulla, or both.
Morphological data suggest that such ischemic injury after
bilateral pedicle clamping occurs both in the cortex and outer
medulla [3]; furthermore, isolated perfused nephron studies
indicate that most nephron segments including proximal convo-
luted and straight tubules, cortical collecting duct and thick
ascending limb of Henle are functionally damaged by 60 mm of
ischemia [23]. The homogenate was centrifuged twice at x750g
at 4°C to remove cellular debris. The resultant supernatant was
then centrifuged at X 10,000g to obtain the Mito fraction. The
Mito pellet was washed twice with media omitting the BSA and
EGTA and resuspended at a concentration of approximately 50
mg protein/ml. Mito protein content was determined by the
method of Murphy and Kies [24] using a spectrophotometer
(model 25, Beckman Instruments Inc., Fullerton, California).
Recovery of Mito from sham versus clamped kidneys was
comparable. Twenty-four hours after ischemia, the recovery of
total Mito protein per milligram of original kidney dry-weight
was the same in both sham (10.34%; N = 6) and ischemic
kidneys (10.35%; N 6). Mittnacht, Sherman, and Farber [25]
have demonstrated similar patterns of recovery in Mito prepa-
rations from sham and ischemic liver. Thus, there was no
evidence that Mito from reversibly or lethally damaged cells are
recovered less well than Mito from normal (sham) kidneys.
Moreover, the activity of succinate dehydrogenase (1M/mg/hr)
as a Mito membrane marker was comparable in Mito pellets
from sham (127.6) and ischemic (176.6) kidneys. Finally, this
enzyme was enriched 6.6-fold from the original homogenate to
the final Mito pellet of ischemic kidneys and 4.7-fold in the
sham-operated rats; also, little, if any, contamination from an
endoplasmic reticulum marker (glucose-6-phosphatase) was ob-
served with this isolation procedure (enrichment less than
onefold in both sham and ischemic preparations).
Mito oxygen (02) consumption was measured polarographi-
cally in a closed reaction vessel fitted with an 02 electrode
(Clark, Yellow Springs Instrument Co., Yellow Springs, Ohio)
at 25°C in a 1,7-mi volume. The incubation medium was
composed of 120 mM KC1, 2 m'vi phosphate, 4 tM rotenone, 1
mM EGTA, and buffered at pH 7.1 with 5 mri Tris-HCI. Mito (2
mg protein) were energized with the addition of 5 mrs'i K-
succinate. After a short equilibration period, state 3 respiration
was induced by the addition of 300 nmoles of adenosine
diphosphate (ADP, Sigma Chemical Corp., St. Louis, Missou-
ri). After all of the added ADP was phosphorylated to adenosine
triphosphate (ATP), state 4 (substrate-stimulated) respiration
was measured. The ratio of 02 consumption in the presence of
ADP to that in its absence (state 3/state 4), termed the acceptor
control ratio (ACR), was used as an indicator of the integrity of
the Mito preparation. In addition, maximal rates of 02 con-
sumption were measured with the addition of 0,2 nmoles FCCP
(Carbonyl cyanide p-trifluoromethoxyphenyl hydrasone, Sigma
Chemical Corp.), an uncoupler of oxidative phosphorylation.
Endogenous Mito Ca and magnesium content were mea-
sured by atomic absorption (370, Perkin-Elmer, Norwalk, Con-
necticut) using 5 mg of Mito protein digested over night in
concentrated nitric acid (200 pi) and diluted to 5 ml with
deionized water. Plasma and urine creatinine and plasma urea
nitrogen concentrations were measured by autoanalyzer meth-
ods; urine and plasma sodium were determined by flame
photometer.
Mito harvested at 1 and 3 hr after ischemia or sham operation
were prepared for electron microscopy. Mito pellets were fixed
in 2.5% gluteraldehyde, 0.1 M sodium phosphate buffer pH 7.4,
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Fig. 1. Changes in serum creatinine (upper panel), mitochondrial
acceptor control ratio (Mito ACR, middle panel), and mitochondrial
calcium (Mito Ca lower panel) during renal pedicle clamping and at
1, 3 to 4, and 24 hr after reflow (•), or after sham operation (0), with
mean I SEM. All data in animals with ischemic acute renal failure are
significantly different from sham controls (Tables 1 to 3).
dehydrated in acetone, postfixed in osmium tetroxide, and
embedded in Spurr's low viscosity embedding medium (Poly
Sciences, Warrington, Pennsylvania). Following block staining
for 1 hr in 2% uranyl acetate, sections were examined and
photographed in an electron microscope (Zeiss 9S2, Carl Zeiss
Optical Instruments, Thornwood, New York).
Statistical analyses were performed using the Student's Un-
paired t test. Values are shown as mean 1 SE.
Results
At the end of the 45-mm period of bilateral renal pedicle
clamping, the serum creatinine level had more than doubled
compared to sham controls (P < 0.001) (Fig. 1, Table 1), and
there was a progressive increase in serum creatinine and blood
urea nitrogen levels at 1 and 3 to 4 hr of reflow after clamping.
Table 1. Serum creatinine and blood urea nitrogen (BUN) levels,
urine to plasma (U/P) creatinine ratio and fractional sodium excretion
(FENa) in rats after 45 mm bilateral renal artery clamping and various
periods of reflow, compared to sham controls (mean I sEM)
Serum
creatinine
mg/dl
BUN
mg/dl
U/P
creatmninea
FENa
%
45-mm Clamp(N=l0) 0.53±0.02 18±1
Sham
(N=5) 0.22±0.02 15±1
P valueb <0.001 NS
1-hr Reflow
(N= 10) 0.68 26±1
Sham(N=7) 0.22±0.03 15±1
P valu&' <0.001 <0.001
3 to 4 hr Reflow
(N=8) 0.89±0.10 35±3
Sham
(N = 7) 0.24 0.03 14 2
P valueb <0.001 <0.001
24-hr Reflow
(N = 12) 1.93 0.27 75 9 13 3 1.17 0.36
Sham
(N = 8) 0.39 0.03 9 1 117 4 0.20 0.08
P value' <0.001 <0.001 <0.001 <0.02
a Creatinine was measured only at 24 hr postischemia.
b The P value compares the experimental with the sham control rats.
Table 2. Mitochondrial respiration (02 consumption, ng atoms 0
mg min ')in rat kidneys after bilateral renal artery clamping for
45 mm and various periods of reflow, compared to sham-operated
control rats (mean I sEM)
State 3 State 4 ACR Uncoupled
45 mm Clamp
(N= 10) 53±10 25.2±3.1 1.96±0.20 78±15
Sham
(N = 7) 141 5 31.2 1.3 4.54 0.15 165 8
P valuea <0.001 NS <0.001 <0.001
1-hr Reflow
(N= 10) 118± 5 32.6± 1.4 3.64±0.12 150± 7
Sham
(N = 7) 144 5 32.8 0.8 4.38 0.11 174 5
P valuea <0.005 NS <0.001 <0.02
3- to 4-hr Reflow
(N = 8) 103 11 28.9 1.1 3.59 0.38 135 13
Sham(N = 7) 155 9 34.0 1.6 4.54 0.11 195 Il
P valuea <0.005 <0.05 <0.05 <0.001
24-hr Reflow
(N=12) 60±13 28.3±3.8 2.01±0.31 74±14
Sham
(N = 8) 138 6 33.9 2.3 4.12 0.12 162 9
P valuea <0.001 NS <0.001 <0.001
Abbreviation: ACR, acceptor control ratio.
a The P value compares the experimental with sham control rats.
Twenty-four hours after 45 mm of bilateral renal pedicle clamp-
ing, the rats demonstrated marked elevations of serum creati-
nine and blood urea nitrogen levels to 1.93 0.27 and 75 9
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Fig. 2. Electron microscopic comparison of Mito isolated from sham-operated or acute renal failure rats. A and B represent Mito from sham rats at
I and 3 hr, respectively. C and D represent Mito from clamped rats at I and 3 hr, respectively. The Mito preparations were similar although there
were possibly more dispersed Mito in the preparation from ischemia animals at I versus at 3 hr; Mito respiration and Mito Ca content, however,
were similar. (x 9,470)
mg/dl, respectively. The urine to plasma creatinine concentra-
tion ratio was reduced and fractional sodium excretion was
increased in animals with ischemic ARF, confirming the pres-
ence of impaired tubular function (Table 1). Urine flow rates in
rats with ischemic ARF were not significantly different from
sham control rats (0.89 0.06 compared to 0.93 0.13 mI/hr in
shams).
The results of assessment of Mito respiration by 02 consump-
tion are shown in Table 2. After bilateral renal pedicle clamping
for 45 mm, there was a marked decrease in state 3 (ADP-
stimulated) respiration (141 5 vs. 53 10 ng atoms 0/mg/mm,
P < 0.001), no significant change in state 4 (succinate-support-
ed) respiration, a decrease in the ACR (state 3/state 4) (4.54
0.15 to 1.96 0.20, P < 0.001), and a decrease in uncoupled
(FCCP) respiration (165 8 to 78 15 ng atoms 0/mg/mm, P <
0.001).
After 1 hr of reflow to the ischemic kidneys, Mito respiration
had improved compared to the end of 45 mm of clamping, with
state 3 respiration doubling (P <0.001), ACR increasing (1.96
0.20 to 3.64 0.12, P < 0.001) and uncoupled respiration
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Mitochondrial calcium Mitochondrial magnesium
45-mm Clamp
Sham
P valu&'
31.7 1.2
23.7 3.1
<0.05
22.7 0.7
21.6 1.4
NS
1-hr Reflow
Sham
P valu&'
43.8 2.9
25.0 1.8
<0.001
23.7 1.1
22.2 0.9
NS
3- to 4-hr Reflow
Sham
P va1ue'
46.1 3.7
25.4 4.0
<0.005
21.2 0.8
24.6 1.1
<0.05
24-hr Reflow
Sham
P valueb
100.9 18.7
29.4 3.2
<0.001
23.3 1.0
20.9 1.0
NS
a N for each group is shown in the table is the same as those in Table
2.
b The P value compares experimental group with sham control rats.
almost doubling (P < 0.001). Nevertheless, Mito respiration
(state 3, ACR, uncoupled) remained significantly depressed
compared to sham-operated controls (Table 2). After 3 to 4 hr of
reflow, the results were not different from 1 hr reflow and the
ACR, although less (3.59 0.38) than control remained higher
than at the end of clamping (P < 0.001). The reduced Mito
respiration did not appear to be due to the morphological
presence of a less homogeneous Mito preparation in ischemic
versus sham kidneys at 1 and 3 hr (Fig. 2). Although Mito were
somewhat more abnormal in appearance at 1 hr compared to 3
hr, Mito respiration and Ca content were very similar.
However, by 24 hr after clamping, when the animals had
established ischemic ARF, Mito respiration was again markedly
decreased with a reduced ACR (2.01 0.31) and similarly with
a decreased state 3 and a decreased uncoupled respiration. This
defect in respiration may have been due to both in vivo and in
vitro Mito Ca accumulation. However, when the Mito were
isolated in the presence of 200 M ruthenium red, which blocks
Mito Ca exchange, there was no significant improvement in
ACR (2.01 0.31 vs. 2.63 0.24, P = NS). Mito Ca content
was also similar, averaging 100.9 18.7 nmoles/mg protein
during isolation with 0.1 mi EGTA and 89.3 20.0 nmoles/mg
during isolation with 200 LM ruthenium red (P NS).
Mito Ca content was slightly higher than control after 45 mm
of renal pedicle clamping (31.7 1.2 vs. 23.7 3.1 nmoles/mg
protein, P < 0.05) (Table 3) and doubled after 1 and 3 to 4 hr of
reflow to the ischemic kidneys (P < 0.001, P <0.005). By 24 hr,
Mito Ca was markedly increased (100.9 18.7 nmoles/mg
protein). Mito magnesium content in ischemic ARF was not
different from sham controls at any of the four periods studied,
except for 3 to 4 hr of reflow at which time it was slightly but
significantly reduced by a mean of 14%.
Linear regression analysis of the results of the three groups of
rats studied after relief of renal pedicle clamping (1, 3 to 4, and
24 hr of reflow) was carried out to further examine the associa-
tion between changes in Mito and renal function during the first
24 hr of reflow after ischemic ARF. There was a highly
significant correlation between increasing Mito Ca content and
decreasing state 3 Mito respiration (r =
—0.89, P < 0.001) (Fig.
3). The increasing serum creatinine level correlated with an
increase in Mito Ca (r = 0.88, P < 0.001) (Fig. 4) and with a
decrease in state 3 respiration (r =
—0.90, P < 0.001) (Fig. 5).
The ACR also demonstrated a highly significant correlation
with increasing Mito Ca (r =
—0.89, P < 0.001) and serum
creatinine (r =
—0.81, P < 0.001) during reflow.
Discussion
In the present study, the renal pedicle clamp model of
ischemic ARF was used to evaluate the sequential changes in
renal and Mito function following 45 mm of renal ischemia in
the rat. Previously, we had preliminarily reported Mito respira-
tory dysfunction and Mito Ca overload at 24 hr after NE-
induced ischemia in the dog [91. Those studies, however, did
not permit us to determine ii the Mito dysfunction was either
the cause of or the result of Mito Ca overload. Thus, the
present experiments were designed to evaluate renal and Mito
function in another species, after a different form of renal
ischemia and, more importantly perhaps, to further examine
whether Mito Ca* overload is simply the result of cell death or
ii it occurs gradually during the period of reflow, thus possibly
contributing to Mito dysfunction. Because Mito function is
essential for cellular viability, and cell death with resultant
debris formation is essential for the tubular obstruction of
ischemic ARF [21], it seemed important to evaluate Mito
function in relationship to the pathogenesis of ischemic ARF.
In the present study, Mito respiration was markedly impaired
immediately after the ischemic insult (prior to reflow), but
substantial improvement occurred after 1 to 4 hr of reflow with
reoxygenation and increased metabolic substrate delivery. The
improvement in Mito respiration was, however, incomplete
and, indeed, Mito respiration worsened significantly 24 hr after
Table 3. Mitochondrial calcium and magnesium content (nanomoles.
mg protein) in rat kidneys after bilateral renal artery clamping for
45 mm and various periods of reflow, compared to sham-operated
control rats (mean SEM)a
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ischemia. Therefore, a major problem is to understand why
reflow is associated with early improvement and then with
further deterioration of Mito function. In this regard, a highly
significant correlation was observed between Mito Ca accu-
mulation and Mito respiration during reperfusion. The Mito
Ca + accumulation occurred early and was relatively selective
since there was no Mito Mg accumulation throughout the
entire 24-hr postischemic period.
Since Mito Ca + accumulation is known to compete with
oxidative phosphorylation and ATP synthesis [261, a relation-
ship between Mito Ca and Mito respiration is possible.
Specifically, the Mito defect in respiration in vitro could be the
result of the Mito Ca+* accumulation in vivo. Alternatively,
Mito Ca accumulation may itself be a marker of other
cellular dysfunction. Recent in vitro results by Lotscher et al
[27] in liver Mito have shown an effect of Ca on Mito
respiration. In their study, a Ca concentration of 100 nmoles/
mg (200 LM/3 mg Mito protein/l.5 ml) caused damage to Mito
membrane potential in the absence of magnesium; a concentra-
tion of 200 nmoles/mg was necessary in the presence of 1 mM
magnesium. These in vitro results in normal liver tissue are,
however, difficult to compare with in vivo events in ischemic
renal tissue. Their results of in vitro Ca loading of normal
liver Mito, however, are not incompatible with the present
observations of a highly significant correlation between Mito
dysfunction and Mito Ca content of ischemic renal tissue.
Finally, recent preliminary studies in our laboratory in chronic
hypercalcemia in the rat suggest that significant defects in Mito
respiration are demonstrable when the Mito have accumulated
as little as 40 nmoles Ca1/mg in vivo [281; these values are
quite comparable to those observed in the early hours of reflow
in the present study.
Thus, the present results obtained over a 24-hr period after
ischemia demonstrated (1) a very early accumulation of Mito
Ca; (2) a highly significant correlation between Mito Ca,
Mito respiration and serum creatinine over the entire 24-hr
period after ischemia; and (3) a selectivity of Mito Ca
accumulation without Mito Mg accumulation and are com-
patible with, but do not prove, a role for Ca in renal cell
death. Such a possibility is supported, however, by the prelimi-
nary observations that a Ca membrane blocker protects
against ischemic renal injury [10, 17, 18]. An additional role of
increased cellular Ca + as a cause of the renal vasoconstriction
associated with ischemic ARF is also quite likely [9, 10, 29—3 1].
Thus a Ca membrane blocker would be expected to exert a
vascular protective effect against renal ischemic injury, in
addition to any protective effect on renal tubular epithelial cells.
Although verapamil has demonstrable effects on the slow Ca
channel of excitable tissue, recent evidence suggests that
verapamil also prevents Ca + translocation in epithelial tissue
[32—34].
It should be emphasized that Mito Ca accumulation oc-
curred predominately during the postischemic period of reflow
with Ca + containing blood rather than during the ischemia per
se. Immediately, before the release of the renal clamp, the
defect in Mito respiration must have been due to anoxia and
substrate deficiency. However, a persistent or progressive
abnormality in the plasmalemma during the reflow period would
contribute to increased cytosolic Ca + necessitatingMito Ca +
buffering. Thus, although the present results support a role of
Mito Ca + in the process of Mito respiratory dysfunction and
cell death, it seems very likely that other important events are
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necessary, such as membrane damage, increased phospholipid
catabolism, and increased membrane permeability [35, 36].
Chien et al [11, 37] described increased phospholipase activity
after liver ischemia which could account for degradation of
membrane phospholipids. An increase in cytosolic Ca + has
been suggested as an important factor in phospholipase activa-
tion [11]. During ischemia impaired Mito ATP synthesis, in
addition to any loss of membrane integrity, would be expected
to also increase cytosolic Na4 [38]. An increase in cytosolic
Na and thus a decrease in the transcellular Na gradient
would be expected to result in less effective Na/Ca ex-
change at the plasmalemma [39]. This event, therefore, along
with impaired Mito Ca + buffering and a defect at the plasma-
lemma which increases Ca permeability directly, could con-
tribute to an increase in cytosolic Ca. This Na/Ca
exchange mechanism, however, may only be operational early
in the postischemic period of reflow [38] since Na concentra-
tion, as measured by electron probe, returns toward normal
very soon after reflow has begun. A persistent increase in Ca
membrane permeability therefore may perpetuate the defect.
In summary, the present results have demonstrated an early,
selective accumulation of Ca by Mito which occurs predomi-
nately during the reflow period. This abnormality correlates
closely with the progressive deterioration of both Mito and total
kidney function. Although a correlation does not prove a cause
and effect relationship, the protective effect of a Ca mem-
brane blocker is compatible with a role of Ca in the patho-
genesis of ischemic injury; moreover, such a defect in Mito
function and Ca overload is most likely interrelated with
other defects such as phospholipase-induced membrane damage.
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